Codex DNA Inc (DNAY) has risen Wednesday morning, with the stock increasing 5.56% in pre-market trading to 2.09. DNAY's short-term technical score of 38 indicates that the stock has traded less bullishly over the last month than 62% of stocks on the market. In the Medical Devices industry, which ranks 122 out of 146 industries, the stock ranks higher than 48% of stocks. Codex DNA Inc has fallen 4.35% over the past month, closing at $1.84 on July 13. During this period of time, the stock fell as low as $1.70 and as high as $2.45. DNAY has an average analyst recommendation of Strong Buy. The company has an average price target of $9.00.
DNAY has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on DNAY!